SEC Filings | Decibel Therapeutics, Inc.

Filing date	Form	Description	View
March 17, 2023	4	Statement of changes in beneficial ownership of securities	0000899243-23-008873.pdf 0000899243-23-008873.rtf 0000899243-23-008873.xls View HTML
March 14, 2023	10-K	Annual report which provides a comprehensive overview of the company for the past year	0000950170-23-007849.pdf 0000950170-23-007849.rtf 0000950170-23-007849.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT View HTML
March 14, 2023	S-8	Securities offered to employees pursuant to employee benefit plans	0000950170-23-007881.pdf 0000950170-23-007881.rtf 0000950170-23-007881.xls View HTML
March 13, 2023	8-K	Report of unscheduled material events or corporate event	0000950170-23-007382.pdf 0000950170-23-007382.rtf 0000950170-23-007382.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
February 14, 2023	SC 13G/A	An amendment to the SC 13G filing	0001104659-23-020734.pdf 0001104659-23-020734.rtf View HTML
February 3, 2023	SC 13G	A statement of beneficial ownership of common stock by certain persons	0001306550-23-006964.pdf 0001306550-23-006964.rtf View HTML
January 30, 2023	4	Statement of changes in beneficial ownership of securities	0000899243-23-002979.pdf 0000899243-23-002979.rtf 0000899243-23-002979.xls View HTML
January 30, 2023	4	Statement of changes in beneficial ownership of securities	0000899243-23-002980.pdf 0000899243-23-002980.rtf 0000899243-23-002980.xls View HTML
January 9, 2023	8-K	Report of unscheduled material events or corporate event	0001193125-23-004217.pdf 0001193125-23-004217.rtf 0001193125-23-004217.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 9, 2022	10-Q	Quarterly report which provides a continuing view of a company's financial position	0000950170-22-023819.pdf 0000950170-22-023819.rtf 0000950170-22-023819.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Main Corporate Nav